Epiq Capital Group, Llc Cortexyme, Inc. (CRTX) insider trading activity

Epiq Capital Group, LLC is of Cortexyme, Inc.. Currently has a direct ownership of 2.83 Million shares of CRTX, which is worth approximately $3.66 Million. The most recent transaction as insider was on Aug 21, 2019, when has been sold 1,635 shares (Common Stock) at a price of $24.87 per share, resulting in proceeds of $40,662. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.83M

0% 3M change

0% 12M change

Total Value Held $3.66 Million

EPIQ Capital Group, LLC Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 21 2019	BUY Open market or private purchase	$40,662 $24.87 p/Share	1,635 Added 0.06%	2,834,561 Common Stock
Aug 20 2019	BUY Open market or private purchase	$59,344 $25.69 p/Share	2,310 Added 0.08%	2,832,506 Common Stock
May 10 2019	BUY Open market or private purchase	$114,883 $26.41 p/Share	4,350 Added 0.15%	2,822,546 Common Stock

Also insider at

AMTI

Applied Molecular Transport Inc. Healthcare

LHDX

Lucira Health, Inc. Healthcare

> 10% Shareholder

ECG